Brief: Deciphera Pharmaceuticals Says If Deal Terminated Under Certain Conditions, Co To Pay ONO Pharmaceutical A Termination Fee Of $78.8 Mln
29/04/2024 13:14
April 29 (Reuters) - Deciphera Pharmaceuticals Inc
DCPH.O :
* DECIPHERA PHARMACEUTICALS INC - IF DEAL TERMINATED UNDER
CERTAIN
CONDITIONS, CO TO PAY ONO PHARMACEUTICAL CO., LTD A TERMINATION
FEE OF $78.8 MILLION
Further company coverage: DCPH.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Deciphera Pharmaceuticals
See all newsBrief: Deciphera Pharmaceuticals Announces Oral Presentation Of Results From Phase 3 Study of Vimseltinib In Patients With Tenosynovial Giant Cell Tumor
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
Deals of the day-Mergers and acquisitions